Extract
Encouragement of regular physical activity is a cornerstone in the treatment of COPD [1], since physical inactivity leads to increased mortality and hospitalisation rates [2, 3]. Additionally, regular physical activity has shown a protective effect on lung function decline in subgroups [4].
Abstract
Although accelerometers are extensively validated to estimate energy expenditure in patients with COPD, they show significant differences in non-worn time and type of activity registration http://bit.ly/32fa7WR
Footnotes
Support statement: This study was supported by Lung Foundation Netherlands grant: 5.1.17.171.0. Funding information for this article has been deposited with the Crossref Funder Registry.
Conflict of interest: M.C. van der Molen has nothing to disclose.
Conflict of interest: J.E. Hartman has nothing to disclose.
Conflict of interest: L.E.G.W. Vanfleteren reports grants, personal fees and nonfinancial support from Pulmonx, personal fees and nonfinancial support from Menarini, grants and personal fees from Astrazeneca, personal fees from Chiesi, GSK, Novartis and Boehringer, and grants and nonfinancial support from Fisher & Paykel, outside the submitted work.
Conflict of interest: D-J. Slebos has nothing to disclose.
- Received September 23, 2019.
- Accepted October 3, 2019.
- Copyright ©ERS 2020
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.